
N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
Keywords: ژن PTEN; Prostate cancer; Androgen signaling; Taxanes; Therapeutic resistance; Epithelial-mesenchymal transition; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; androgen receptor splice variant; CRPC; castration-resistant prostate cancer; DHT; dih